Report Detail
Generic Drugs Market By Brand (Pure generic drugs, Branded generic drugs), By Therapeutic Application (Central nervous system (CNS), Cardiovascular, Dermatology, Oncology, Respiratory), Industry Trends, Estimation & Forecast, 2018-2025
- RnM3857481 |
- 23 December, 2019 |
- Global |
- 168 Pages |
- Esticast Research & Consulting |
- Pharma & Healthcare
“Generic Drugs Market” 2018-2026 report is a professional study on the current state of the market that focuses on the major drivers, challenges, opportunities for the leading players. The research report also offers a granular analysis of various definitions, and classification of the industry, applications of the industry, regional breakdown, opportunities, challenges, and chain structure.
About Generic Drugs Market
Generic Drugs Market is expected to grow with a CAGR of 8% during the forecast period of 2018 to 2025. Generic drugs are pharmacologically equivalent drugs to the patented ones, containing same active pharmaceutical ingredient, but available at reduced costs in comparison to the patented drugs, owing to the absence of R&D as well as novel drug development costs. Increasing number of patent expiration of branded drugs is one of the major reasons which is stimulating the market growth. In addition, an increasing prevalence of chronic diseases such as cancer and tuberculosis is also a major catalyst which is amplifying the market growth. The National Institute of Cancer Prevention and Research has estimated that there are around 2.5 million people in India, who are living with cancer.
Market Summary:
The Generic Drugs market is a comprehensive report which offers a meticulous overview of the market share, size, trends, demand, product analysis, application analysis, regional outlook, competitive strategies, forecasts, and strategies impacting the Generic Drugs Industry. The report includes a detailed analysis of the market competitive landscape, with the help of detailed business profiles, SWOT analysis, project feasibility analysis, and several other details about the key companies operating in the market.
The study on the worldwide Generic Drugs market strives to offer substantial and profound insights into the current market scenario and the developing growth dynamics. Moreover, the report also provides the market players along with the new contenders a complete view of the market landscape. The inclusive research will enable the well-established as well as the entry-level players to establish their business strategies and accomplish their short-term and long-term goals.
Scope and Segmentation of the Report
The segment analysis is one of the significant sections of this report. Our expert analyst has categorized the market into product type, application/end-user, and geography. All the segments are analyzed based on their market share, growth rate, and growth potential. In the geographical classification, the report highlights the regional markets having high growth potential. This thorough evaluation of the segments would help the players to focus on revenue-generating areas of the Generic Drugs market.
Based on Type
By Brand
Pure generic drugs
Branded generic drugs
Based on Application
Central nervous system (CNS)
Cardiovascular
Dermatology
Oncology
Respiratory
Others
Regional Analysis
Our analysts are experts in covering all types of geographical markets from developing to mature ones. You can expect a comprehensive research analysis of key regional and country-level markets such as Europe, North America, South America, Asia-Pacific, and the Middle East & Africa. With accurate statistical patterns and regional classification, our domain experts provide you one of the most detailed and easily understandable regional analyses of the Generic Drugs market.
Competitive Landscape:
The research report also studied the key players operating in the Generic Drugs market. It has evaluated and explained the research & development stages of these companies, their financial performances, and their expansion plans for the coming years. Moreover, the research report also includes the list of planned initiatives that clearly explain the accomplishments of the companies in the recent past.
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products, etc.):
Ranbaxy Laboratories
Ltd
Actavis
Mylan
Inc.
Teva Pharmaceutical Industries
Ltd.
Sandoz International GmbH
Dr. Reddy’s Laboratories
Apotex
Inc.
Par Pharmaceutical
Inc.
Hospira
Inc.
Watson Pharmaceuticals
Ltd.
Others
Research Methodology
The research methodology of the market is based on both primary as well as secondary research data sources. It compels different factors affecting the Generic Drugs industry such as historical data and market trends, different policies of the government, market environment, market risk factors, market restraints, technological advancements, forthcoming innovations, and obstacles in the industry.
The content of the study subjects includes a total of 8 chapters:
Chapter 1, describe the Generic Drugs market report’s – executive summary, market definition, and market scope. Moreover, the report helps in picking up the crucial information about the said market.
Chapter 2, defines the Research Methodology including primary research, assumptions & exclusions, and secondary data sources. The report follows the simultaneous top-down and bottom approach to provide you the accurate market sizing.
Chapter 3, explains the report segmentation & scope, key market trends (drivers, restraints, and opportunities), along with Porter’s five forces analysis and market share analysis
Chapter 4: It helps in understanding the key product segments and their future of the Generic Drugs Market. It provides strategic recommendations in key business segments based on the market estimations.
Chapters 5, and 6 to segment the sales by type and application/end-user, with sales market share and growth rate by type, application/end-user, from 2018 to 2016. Our team of Analysts and experts dedicatedly put their effort to provide you the best possible and accurate segmentation data and analysis.
Chapter 7, describes the regional segmentation based on the country level for the forecast period 2018 – 2026. The research report not only provide the market data of the five geographies but also provide the qualitative as well we qualitative information on country level bifurcation.
Chapter 8, to profile the top manufacturers of Generic Drugs, with price, sales, revenue and market share of Generic Drugs in 2016, 2017, and 2018. Players are expected to sign acquisition and collaboration deals to expand their products and services portfolio. Such strategic agreements could help them to improve their client base in other countries and gain a competitive advantage
CHAPTER 1. INTRODUCTION
- 1.1. RESEARCH METHODOLOGY
- 1.1.1. ERC DESK RESEARCH
- 1.1.2. ERC DATA SYNTHESIS
- 1.1.3. DATA VALIDATION AND MARKET FEEDBACK
- 1.1.4. ERC DATA SOURCES
CHAPTER 2. GENERIC DRUGS MARKET OVERVIEW
- 2.1. GENERIC DRUGS MARKET INTRODUCTION
- 2.2. GLOBAL GENERIC DRUGS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
- 2.2.1. GLOBAL GENERIC DRUGS PRODUCTION (VOLUME) AND GROWTH RATE (%), (2017-2025)
- 2.3. GLOBAL GENERIC DRUGS MARKET CAPACITY AND GROWTH RATE, 2017-2025
- 2.3.1. GLOBAL GENERIC DRUGS CAPACITY (VOLUME) AND GROWTH RATE (%), (2017-2025)
- 2.4. GLOBAL GENERIC DRUGS MARKET REVENUE AND GROWTH RATE, 2017-2025
- 2.4.1. GLOBAL GENERIC DRUGS MARKET REVENUE (MILLION USD) AND GROWTH RATE (%), (2017-2025)
- 2.5. GLOBAL GENERIC DRUGS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
- 2.5.1. GLOBAL GENERIC DRUGS CONSUMPTION (VOLUME) AND GROWTH RATE (%), (2017-2025)
CHAPTER 3. GLOBAL GENERIC DRUGS MARKET BY BRAND, 2017-2025
- 3.1. PURE GENERIC DRUGS
- 3.2. BRANDED GENERIC DRUGS
- 3.3. GLOBAL GENERIC DRUGS MARKET REVENUE BY BRAND, 2017-2025
- 3.3.1. GLOBAL GENERIC DRUGS MARKET REVENUE (MILLION USD) AND SHARE (%) BY BRAND, 2017-2025
- 3.3.2. PURE GENERIC DRUGS MARKET REVENUE AND GROWTH RATE, 2017-2025
- 3.3.3. BRANDED GENERIC DRUGS MARKET REVENUE AND GROWTH RATE, 2017-2025
- 3.4. GLOBAL GENERIC DRUGS MARKET PRODUCTION BY BRAND, 2017-2025
- 3.4.1. GLOBAL GENERIC DRUGS MARKET PRODUCTION (VOLUME) AND SHARE (%) BY BRAND, 2017-2025
- 3.4.2. PURE GENERIC DRUGS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
- 3.4.3. BRANDED GENERIC DRUGS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
CHAPTER 4. GLOBAL GENERIC DRUGS MARKET BY THERAPEUTIC APPLICATION, 2017-2025
- 4.1. CENTRAL NERVOUS SYSTEM (CNS)
- 4.2. CARDIOVASCULAR
- 4.3. DERMATOLOGY
- 4.4. ONCOLOGY
- 4.5. RESPIRATORY
- 4.6. OTHERS
- 4.7. GLOBAL GENERIC DRUGS MARKET REVENUE BY THERAPEUTIC APPLICATION, 2017-2025
- 4.7.1. GLOBAL GENERIC DRUGS MARKET REVENUE (MILLION USD) AND SHARE (%) BY THERAPEUTIC APPLICATION, 2017-2025
- 4.7.2. CENTRAL NERVOUS SYSTEM (CNS) MARKET REVENUE AND GROWTH RATE, 2017-2025
- 4.7.3. CARDIOVASCULAR MARKET REVENUE AND GROWTH RATE, 2017-2025
- 4.7.4. DERMATOLOGY MARKET REVENUE AND GROWTH RATE, 2017-2025
- 4.8. GLOBAL GENERIC DRUGS MARKET CONSUMPTION BY THERAPEUTIC APPLICATION, 2017-2025
- 4.8.1. GLOBAL GENERIC DRUGS MARKET CONSUMPTION (VOLUME) AND SHARE (%) BY THERAPEUTIC APPLICATION, 2017-2025
- 4.8.2. CENTRAL NERVOUS SYSTEM (CNS) MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
- 4.8.3. CARDIOVASCULAR MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
- 4.8.4. DERMATOLOGY MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
CHAPTER 5. GLOBAL GENERIC DRUGS MARKET BY REGION, 2017-2025
- 5.1. NORTH AMERICA
- 5.1.1. U.S.
- 5.1.2. CANADA
- 5.1.3. MEXICO
- 5.2. EUROPE
- 5.2.1. U.K.
- 5.2.2. FRANCE
- 5.2.3. GERMANY
- 5.2.4. ITALY
- 5.2.5. SPAIN
- 5.2.6. REST OF EUROPE
- 5.3. ASIA PACIFIC
- 5.3.1. CHINA
- 5.3.2. JAPAN
- 5.3.3. INDIA
- 5.3.4. KOREA
- 5.3.5. REST OF APAC
- 5.4. SOUTH AMERICA
- 5.4.1. BRAZIL
- 5.4.2. REST OF SOUTH AMERICA
- 5.5. REST OF THE WORLD
- 5.5.1. MIDDLE EAST
- 5.5.2. AFRICA
- 5.6. GLOBAL GENERIC DRUGS MARKET REVENUE BY REGION, 2017-2025
- 5.6.1. GLOBAL GENERIC DRUGS MARKET REVENUE (MILLION USD) AND SHARE (%) BY REGION, 2017-2025
- 5.6.2. NORTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
- 5.6.3. EUROPE MARKET REVENUE AND GROWTH RATE, 2017-2025
- 5.6.4. ASIA PACIFIC MARKET REVENUE AND GROWTH RATE, 2017-2025
- 5.6.5. SOUTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
- 5.6.6. REST OF THE WORLD MARKET REVENUE AND GROWTH RATE, 2017-2025
CHAPTER 6. GLOBAL GENERIC DRUGS MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
- 6.1. GLOBAL GENERIC DRUGS MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
- 6.1.1. GLOBAL GENERIC DRUGS MARKET PRODUCTION (VOLUME) AND SHARE (%) BY REGION, 2017-2025
- 6.1.2. GLOBAL GENERIC DRUGS MARKET CONSUMPTION (VOLUME) AND SHARE (%) BY REGION, 2017-2025
- 6.1.3. NORTH AMERICA MARKET PRODUCTION AND CONSUMPTION, 2017-2025
- 6.1.4. EUROPE MARKET PRODUCTION AND CONSUMPTION, 2017-2025
- 6.1.5. ASIA PACIFIC MARKET PRODUCTION AND CONSUMPTION, 2017-2025
- 6.1.6. SOUTH AMERICA MARKET PRODUCTION AND CONSUMPTION, 2017-2025
- 6.1.7. REST OF THE WORLD MARKET PRODUCTION AND CONSUMPTION, 2017-2025
CHAPTER 7. MARKET DETERMINANTS
- 7.1. MARKET DRIVERS
- 7.2. MARKET RESTRAINTS
- 7.3. MARKET OPPORTUNITIES
- 7.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 8. GLOBAL GENERIC DRUGS MARKET COMPETITION BY MANUFACTURERS
- 8.1. GLOBAL GENERIC DRUGS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
- 8.1.1. GLOBAL GENERIC DRUGS PRODUCTION (VOLUME) AND SHARE (%) BY MANUFACTURERS (2017-2025)
- 8.2. GLOBAL GENERIC DRUGS REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
- 8.2.1. GLOBAL GENERIC DRUGS REVENUE (MILLION USD) AND SHARE (%) BY MANUFACTURERS (2017-2025)
- 8.3. GENERIC DRUGS MARKET COMPETITIVE SITUATION AND TRENDS
- 8.3.1. GENERIC DRUGS MARKET SHARE (%) OF TOP 3 MANUFACTURERS
- 8.3.2. GENERIC DRUGS MARKET SHARE (%) OF TOP 5 MANUFACTURERS
CHAPTER 9. GLOBAL GENERIC DRUGS MANUFACTURERS ANALYSIS
- 9.1. RANBAXY LABORATORIES, LTD
- 9.1.1. BUSINESS OVERVIEW
- 9.1.2. COMPANY BASIC INFORMATION
- 9.1.3. GENERIC DRUGS PRODUCT DETAILS
- 9.1.4. RANBAXY LABORATORIES, LTD GENERIC DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
- 9.2. ACTAVIS
- 9.2.1. BUSINESS OVERVIEW
- 9.2.2. COMPANY BASIC INFORMATION
- 9.2.3. GENERIC DRUGS PRODUCT DETAILS
- 9.2.4. ACTAVIS GENERIC DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
- 9.3. MYLAN, INC.
- 9.3.1. BUSINESS OVERVIEW
- 9.3.2. COMPANY BASIC INFORMATION
- 9.3.3. GENERIC DRUGS PRODUCT DETAILS
- 9.3.4. MYLAN, INC. GENERIC DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
- 9.4. TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- 9.4.1. BUSINESS OVERVIEW
- 9.4.2. COMPANY BASIC INFORMATION
- 9.4.3. GENERIC DRUGS PRODUCT DETAILS
- 9.4.4. TEVA PHARMACEUTICAL INDUSTRIES, LTD. GENERIC DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
- 9.5. SANDOZ INTERNATIONAL GMBH
- 9.5.1. BUSINESS OVERVIEW
- 9.5.2. COMPANY BASIC INFORMATION
- 9.5.3. GENERIC DRUGS PRODUCT DETAILS
- 9.5.4. SANDOZ INTERNATIONAL GMBH GENERIC DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
- 9.6. DR. REDDY’S LABORATORIES
- 9.6.1. BUSINESS OVERVIEW
- 9.6.2. COMPANY BASIC INFORMATION
- 9.6.3. GENERIC DRUGS PRODUCT DETAILS
- 9.6.4. DR. REDDY’S LABORATORIES GENERIC DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
- 9.7. PAR PHARMACEUTICAL, INC.
- 9.7.1. BUSINESS OVERVIEW
- 9.7.2. COMPANY BASIC INFORMATION
- 9.7.3. GENERIC DRUGS PRODUCT DETAILS
- 9.7.4. PAR PHARMACEUTICAL, INC. GENERIC DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
- 9.8. APOTEX, INC.
- 9.8.1. BUSINESS OVERVIEW
- 9.8.2. COMPANY BASIC INFORMATION
- 9.8.3. GENERIC DRUGS PRODUCT DETAILS
- 9.8.4. APOTEX, INC. GENERIC DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
- 9.9. HOSPIRA, INC.
- 9.9.1. BUSINESS OVERVIEW
- 9.9.2. COMPANY BASIC INFORMATION
- 9.9.3. GENERIC DRUGS PRODUCT DETAILS
- 9.9.4. HOSPIRA, INC. GENERIC DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
- 9.10. WATSON PHARMACEUTICALS, LTD.
- 9.10.1. BUSINESS OVERVIEW
- 9.10.2. COMPANY BASIC INFORMATION
- 9.10.3. GENERIC DRUGS PRODUCT DETAILS
- 9.10.4. WATSON PHARMACEUTICALS, LTD. GENERIC DRUGS PRODUCTION, REVENUE AND GROSS MARGIN
CHAPTER 10. GENERIC DRUGS MARKET VALUE CHAIN ANALYSIS
- 10.1. GENERIC DRUGS INDUSTRIAL CHAIN ANALYSIS
- 10.2. GENERIC DRUGS KEY RAW MATERIALS ANALYSIS
- 10.2.1. KEY RAW MATERIALS
- 10.2.2. PRICE TREND OF KEY RAW MATERIALS
- 10.2.3. KEY SUPPLIERS OF RAW MATERIALS
- 10.3. CONSUMER ANALYSIS
- 10.3.1. CONSUMER 1
- 10.3.2. CONSUMER 2
- 10.3.3. CONSUMER 3
Summary:
Get latest Market Research Reports on Generic Drugs . Industry analysis & Market Report on Generic Drugs is a syndicated market report, published as Generic Drugs Market By Brand (Pure generic drugs, Branded generic drugs), By Therapeutic Application (Central nervous system (CNS), Cardiovascular, Dermatology, Oncology, Respiratory), Industry Trends, Estimation & Forecast, 2018-2025. It is complete Research Study and Industry Analysis of Generic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
